Voyageur Pharmaceuticals Ltd.
VYYRF
$0.10
$0.0110.23%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.50K | 8.00K | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.50K | 8.00K | -- | -- | -- |
| Cost of Revenue | 8.50K | 10.10K | -- | -- | -- |
| Gross Profit | -100.00 | -2.10K | -- | -- | -- |
| SG&A Expenses | 2.07M | 1.80M | 1.25M | 1.36M | 1.11M |
| Depreciation & Amortization | 800.00 | 900.00 | 1.00K | 1.10K | 1.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.08M | 1.81M | 1.26M | 1.36M | 1.11M |
| Operating Income | -2.07M | -1.80M | -1.26M | -1.36M | -1.11M |
| Income Before Tax | -2.53M | -2.24M | -1.55M | -1.58M | -1.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.53 | -2.24 | -1.55 | -1.58 | -1.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.53M | -2.24M | -1.55M | -1.58M | -1.25M |
| EBIT | -2.07M | -1.80M | -1.26M | -1.36M | -1.11M |
| EBITDA | -2.07M | -1.80M | -1.25M | -1.36M | -1.11M |
| EPS Basic | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 662.51M | 623.53M | 595.53M | 573.24M | 550.46M |
| Average Diluted Shares Outstanding | 662.51M | 623.53M | 595.53M | 573.24M | 550.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |